Selective CDK4/6 Inhibitors in Cancer: Moving Beyond Breast Cancer

Learning Module - Richard Finn, MD; Gary K. Schwartz, MD; and Geoffrey Shapiro, MD, PhD, discuss the supporting rationale and emerging role of selective CDK4/6 inhibitors in multiple types of cancer.

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oiGsbc
via IFTTT